TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors

Recruiting now · Phase 3

Conditions studied: Ovarian Germ Cell Cancer, Ovarian Neoplasms, Ovarian Cancer

In brief

Investigators will conduct the trial to determine whether paclitaxel and cisplatin (PT) has the same curative effects and less adverse effects than bleomycin, etoposide and cisplatin(BEP) among newly diagnosed malignant ovarian germ cell tumor patients after surgery.

Key facts

Study ID
NCT02429687
Run by
Beihua Kong
People needed
129
Starts
2015-04-01
Expected to finish
2030-05-01
Last updated by the study team
2023-04-25

Who can join

Age: 14 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.